Nephrology Doctors in Glendale, WI Accepting Medicare

6 Nephrology doctors found. Showing 1 - 6

Talal R Khairi, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5650 N Green Bay Ave Ste 210, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

Dr. Rishi Kora, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5650 N Green Bay Ave Ste 210, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

Dr. Stephen Glenn Sievers, M.D. Internal Medicine - Nephrology Medicare: Medicare Enrolled Practice Location: 5650 N Green Bay Ave Ste 100, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

Dr. Lisa Haller, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5650 N Green Bay Ave Ste 210, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

Dr. Kamal Amin, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5650 N Green Bay Ave Ste 210, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

Anushayanthan Alfred, M.D., M.P.H Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 5650 N Green Bay Ave Ste 210, Glendale, WI 53209 Phone: 414-431-5971    Fax: 414-434-0354

News Archive

Drugs for prevention of breast cancer

According to an international panel of cancer experts, women at high risk of developing breast cancer should be given preventative drugs. The experts write in the Lancet Oncology adding, drugs such as tamoxifen could reduce the chances of developing breast cancer. They suggest that this would be something similar to prescribing statins to patients at risk of heart disease. But tamoxifen has been linked with womb cancer, blood clots and stroke.

Health law preparations go full throttle

The re-election of President Barack Obama all but ensured the survival of the law, news outlets report. Now, a slew of regulations must be issued and political and financial and organizational obstacles overcome.

Researchers are studying tailored treatments to improve prostate cancer care

Researchers from the University of Glasgow are leading a study into individualized treatments for prostate cancer.

Merck & Co and Cardiome sign agreement for Vernakalant

Merck & Co., Inc. and Cardiome Pharma Corp. has announced a collaboration and license agreement for the development and commercialization of vernakalant, an investigational candidate for the treatment of atrial fibrillation.

Read more Medical News

› Verified 7 days ago